The Avivia approach

Avivia’s internal product development programs are focused on the reformulation and/or repositioning of established drug products. Although we usually tend to operate in a flexible and pragmatic way, when it comes to the selection of our internal product candidates we do follow a set of stringent selection criteria. First and foremost, our development programs are all based on a strong clinical need and market demand, supported by top-tier (clinical) Key Opinion Leaders. Secondly, we only select product programs which have a high potential to improve the Target Product Profile of the selected product (i.e. safety, efficacy and/or convenience of use). Thirdly, we do seek programs for which we can develop a strong exclusivity position. Finally, we do favor projects with low overall investment requirements and short time-to-market horizons aiming for attractive risk/return product profiles. Although we typically develop our internal programs up to clinical proof-of-concept, if needed we will also go all the way up to the registration of a product dossier at which point we will seek for a commercialization partner.